QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

ATEC

QT67Alphatec Holdings, Inc.
NASDAQ·Healthcare·Medical - Devices·USA
Latest market price
8.81
+0.57+6.92%
OverviewShort InterestFilings
ATECQT67Alphatec Holdings, Inc.·NASDAQ
OverviewShort InterestFilings
8.81+6.92%
TA
Loading chart...
Screen all →
ABT-0.10%$88.41ISRG+1.14%$406.78SYK+2.21%$307.80MDT+1.54%$79.34BSX+0.76%$45.29EW+0.78%$87.36DXCM+1.74%$72.47RMD+1.26%$188.63
Snapshot
Index-P/E-EPS (ttm)-0.83
Insider Own-
Shs Outstand153.79M
Perf Week8.36%
Market Cap1.27BForward P/E15.19EPS next Y0.58Insider Trans-0.05%Shs Float-Perf Month7.18%
Enterprise Value1.73BPEG-EPS next Q0.09Inst Own-Short Float-Perf Quarter-30.74%
Income-125201470.00P/S1.61EPS this Y138.55%Inst Trans-Short Ratio-Perf Half Y-55.41%
Sales787.07MP/B69.53EPS next Y81.25%ROA-15.68%Short Interest-Perf YTD-58.13%
Book/sh0.12P/C24.62EPS next 5Y49.30%ROE-443.09%52W High23.29 -62.17%Perf Year-18.80%
Cash/sh0.91P/FCF182.36EPS past 3/5Y-ROIC-8.94%52W Low6.82 29.18%Perf 3Y-
Dividend Est.-EV/EBITDA-1277.03Sales past 3/5Y29.60% 39.43%Gross Margin65.32%Volatility3.11% 3.10%Perf 5Y-
Dividend TTM-EV/Sales2.20EPS Y/Y TTM90.27%Oper. Margin-7.17%ATR (14)0.46Perf 10Y-
Dividend Ex-Date-Quick Ratio1.12Sales Y/Y TTM28.76%Profit Margin-15.93%RSI (14)57.42Recom2.11
Dividend Gr. 3/5Y-Current Ratio1.90EPS Q/Q4.35%SMA209.39%Beta0.54Target Price18.00
Payout0.00%Debt/Eq33.03Sales Q/Q13.61%SMA50-1.45%Rel Volume1.24Prev Close8.24
Employees867LT Debt/Eq15.25EarningsJul 30SMA200-38.91%Avg Volume3.55MPrice8.81
IPO DateJun 12, 2006Option/ShortYes / YesEPS/Sales Surpr.-2100.00% -3.03%Net Debt/EBITDA-341.81Volume4,421,345Change6.92%
Analyst Ratings
DateActionAnalystRatingTarget
May-06-26ReiteratedLake StreetBuy$25 → $15
May-06-26ReiteratedPiper SandlerOverweight$25 → $14
May-06-26ReiteratedNeedhamBuy$23 → $14
May-06-26ReiteratedCanaccord GenuityBuy$25 → $23
Jan-07-26ReiteratedBarclaysOverweight$23 → $27
Dec-10-25ReiteratedLoop Capital Markets$25
Dec-02-25ReiteratedMorgan StanleyEqual Weight$21 → $23
Nov-10-25ReiteratedMorgan StanleyEqual Weight$8.00 → $21
Nov-03-25ReiteratedBarclaysOverweight$19 → $23
Oct-31-25ReiteratedLake StreetBuy$18 → $25
Latest News
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/30/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue788764612
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A273232187
Gross Profit513532424
Selling, General and Administrative Excl. Other493499450
Research and Development787681
Other Operating Expense-13929
Operating Income-56-82-136
Interest Expense422125
Unusual Expense
———
Non-Operating Income (Expense)27401
Net Income Before Taxes-126-143-162
Income Taxes000
Consolidated Net Income-126-143-162
Net Income From Continuing Operations-126-143-162
Net Income-126-143-162
EPS (Recurring)-0.83-0.96-1.13
EPS (Basic, Before Extraordinaries)-0.83-0.96-1.13
EPS (Diluted)-0.83-0.96-1.13
EBITDA-1-40-54
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio1.724.13—
Gross Margin65.1069.6369.28
Operating Margin-7.11-10.73-22.22
Net Margin-15.99-18.72-26.47
Shares Outstanding154150143
Market Capitalization1,3573,156—
Operating Lease Expense
———
Insider Trading Volume
$10.64$9.78$8.92$8.05$7.19● Close Price0.00M12.26M24.52M36.78M49.04MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
MCGINNIS KAREN KDirectorJun 11 '26Sale8.016,05048,46194,671Jun 12 12:00 AM
Valentine KeithDirectorMay 11 '26Buy7.0035,000245,000232,271May 11 12:00 AM
Valentine KeithDirectorMay 08 '26Buy7.5443,847330,606197,271May 11 12:00 AM
Valentine KeithDirectorMay 07 '26Buy7.4956,153420,586153,424May 11 12:00 AM
Marshall Tyson EliotGENERAL COUNSEL & CORP. SEC.Apr 07 '26Option Exercise2.52205,000516,100661,959Apr 09 12:00 AM
Koning John ToddCHIEF FINANCIAL OFFICERMar 13 '26Sale12.3679,789986,192600,721Mar 17 12:00 AM
Lish ScottCHIEF OPERATING OFFICERMar 13 '26Sale12.30260,5353,204,581815,704Mar 17 12:00 AM
Sponsel DavidEVP, SALESMar 11 '26Sale12.52163,4522,046,419504,932Mar 13 12:00 AM
Hunsaker Craig EEVP, PEOPLE & CULTUREMar 09 '26Sale12.4582,7651,030,4241,726,209Mar 10 12:00 AM
Hunsaker Craig EEVP, PEOPLE & CULTUREMar 06 '26Sale12.2233,602410,6161,808,974Mar 10 12:00 AM
Marshall Tyson EliotGENERAL COUNSEL & CORP. SEC.Mar 05 '26Sale12.4988,8351,109,549559,459Mar 09 12:00 AM
Hunsaker Craig EEVP, PEOPLE & CULTUREFeb 12 '26Option Exercise2.14502,3521,077,0021,424,201Feb 17 12:00 AM
Sponsel DavidEVP, SALESFeb 05 '26Sale13.7960,425833,261349,500Feb 06 12:00 AM
Hunsaker Craig EEVP, PEOPLE & CULTUREFeb 03 '26Sale14.7137,358549,5361,173,025Feb 04 12:00 AM
Miles PatrickCEOJan 05 '26Sale21.01100,0002,101,0005,135,398Jan 06 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR